🏛️ Verified NIH Record • Updated 2025-07-08
A Study to Determine the Safety and Efficacy of NT-501 With MHFM (NCT06397131)
A Multicenter Study to Determine the Safety and Efficacy of NT-501 Utilizing the Medica Membrane in Macular Telangiectasia Type 2
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Neurotech Pharmaceuticals
🩺 Plain-English Summary (8th-Grade Level)
This study is to determine the long-term levels of CNTF, and the clinical safety and efficacy of the NT-501 implants with the Medica Hollow Fiber Membrane (MHFM) in participants with macular telangiectasia type 2.
Who can join: Review the eligibility criteria below.
Location: Bay Area Retina Associates, A Medical Group — Walnut Creek, California
Age range: 21 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Bay Area Retina Associates, A Medical Group — Walnut Creek, California
- Foundation for Vision Research — Grand Rapids, Michigan
- Retina Consultants of Texas — Bellaire, Texas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Macular Telangiectasia Type 2
- Serine and Fenofibrate Study in Patients With MacTel Type 2 — Atlanta, Georgia
Explore by condition: All Macular Telangiectasia Type 2 clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.